Format

Send to

Choose Destination
Fam Cancer. 2016 Jul;15(3):385-93. doi: 10.1007/s10689-016-9882-8.

Update on Lynch syndrome genomics.

Author information

1
Department of Medical and Clinical Genetics, University of Helsinki, P. O. Box 63, Haartmaninkatu 8, 00014, Helsinki, Finland. Paivi.Peltomaki@Helsinki.Fi.

Abstract

Four main DNA mismatch repair (MMR) genes have been identified, MLH1, MSH2, MSH6, and PMS2, which when mutated cause susceptibility to Lynch syndrome (LS). LS is one of the most prevalent hereditary cancer syndromes in man and accounts for 1-3 % of unselected colorectal carcinomas and some 15 % of those with microsatellite instability and/or absent MMR protein. The International Society for Gastrointestinal Hereditary Tumours (InSiGHT) maintains a database for LS-associated mutations since 1996. The database was recently reorganized to efficiently gather published and unpublished data and to classify the variants according to a five-tiered scheme linked to clinical recommendations. This review provides an update of germline mutations causing susceptibility to LS based on information available in the InSiGHT database and the latest literature. MMR gene mutation profiles, correlations between genotype and phenotype, and possible mechanisms leading to the characteristic spectrum of tumors in LS are discussed in light of the different functions of MMR proteins, many of which directly serve cancer avoidance.

KEYWORDS:

DNA mismatch repair; Epimutation; Lynch syndrome; Mutation; Tumor spectrum

PMID:
26873718
PMCID:
PMC4901089
DOI:
10.1007/s10689-016-9882-8
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center